BGLAF (BioGaia AB) Inventory Turnover: 0.63 (As of Mar. 2026)

What is BioGaia AB Inventory Turnover?

BioGaia AB BGLAF 100 Inventory Turnover is 0.63 as of Mar. 2026. GuruFocus rates BGLAF with a GF Score™ of 100/100 and a GF Value™ of $13.05. The stock has 5 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. BioGaia AB's Cost of Goods Sold for the three months ended in Mar. 2026 was $11.4 Mil. BioGaia AB's Average Total Inventories for the quarter that ended in Mar. 2026 was $17.9 Mil. BioGaia AB's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.63.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. BioGaia AB's Days Inventory for the three months ended in Mar. 2026 was 144.19.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BioGaia AB's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.45.

BioGaia AB (OTCPK:BGLAF) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

BioGaia AB's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	17.938	/	11.352	*	365 / 4
	=	144.19

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

BioGaia AB's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	17.938	/	39.985
	=	0.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

BioGaia AB Inventory Turnover Related Terms

BioGaia AB Inventory Turnover Historical Data

* Premium members only.

The historical data trend for BioGaia AB's Inventory Turnover can be seen below:

BioGaia AB Inventory Turnover Chart

BioGaia AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

2.23

2.32

2.15

2.26

2.77

BioGaia AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.69	0.00	0.00	0.70	0.63

100GF Score

BioGaia AB BGLAF

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

BioGaia AB Inventory Turnover Calculation

BioGaia AB's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	44.072	/ (	(13.918	+	17.938)	/	2 )
=	44.072	/	15.928
=	2.77

BioGaia AB's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	11.352	/ (	(17.938	+	0)	/	1 )
=	11.352	/	17.938
=	0.63

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.63 mean?

BioGaia AB (BGLAF) has a Inventory Turnover of 0.63 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on BioGaia AB and its competitors.

Is BioGaia AB's Inventory Turnover too high?

BioGaia AB's current Inventory Turnover is 0.63. Overall, BioGaia AB has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.

How does BioGaia AB's Inventory Turnover compare to ZTS?

BioGaia AB's Inventory Turnover of 0.63 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Drug Manufacturers company?

A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on BioGaia AB and its competitors. BioGaia AB's current Inventory Turnover is 0.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is BioGaia AB stock overvalued right now?

BioGaia AB (BGLAF) has a current Inventory Turnover of 0.63. The stock's GF Value™ is $13.05, compared to a current price of $12.20 — trading 6.5% below its estimated fair value. The current Inventory Turnover is 0.63. BioGaia AB's overall GF Score™ is 100/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For BioGaia AB (BGLAF), the current Inventory Turnover is 0.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioGaia AB (BGLAF) Overvalued in 2026?

Based on GuruFocus' analysis, BioGaia AB stock appears to be undervalued. The current stock price of $12.20 is trading 6.5% below its estimated GF Value™ of $13.05.

Key valuation signals for BGLAF:

Inventory Turnover: 0.63
GF Value™: $13.05 vs. price of $12.20 (6.5% below fair value)
GF Score™: 100/100 with 5 warning signs

No single metric tells the full story. See the BGLAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioGaia AB Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies OSTO:CRNO B OSTO:NANEXA OSTO:EQL OSTO:ORX OSTO:ENZY OSTO:CINPHA OSTO:MOB OSTO:DICOT OSTO:KLAR XSAT:ACUC XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692

Other Exchanges BIOG B:Sweden 0GTN:UK BGLA:Germany

Address Kungsbroplan 3A, Stockholm, SWE, SE-112 27

Website https://www.biogaiagroup.com

BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions: EMEA, the Americas, and APAC (Asia-Pacific, Australia, and New Zealand).

100GF Score

Get the complete analysis for BGLAF

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.20

Price

$13.05

GF Value

View BGLAF Analysis

See Inventory Turnover data for all stocks →